Related Experiment Video
Updated: Jan 14, 2026

12:57
Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
16.5K
Beyond prion-like spreading in neurodegenerative disease
Georg Meisl1,2, James B Rowe3, David Klenerman1,2
1Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|October 21, 2025
Summary
Understanding protein aggregation in neurodegenerative diseases is key for therapies. A new framework, beyond the
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Neurodegenerative diseases like Alzheimer's and Parkinson's involve protein aggregation.
- These aggregates can seed further aggregation, leading to a
Purpose of the Study:
- To propose a more nuanced framework for understanding protein aggregation and spreading in neurodegenerative diseases.
- To move beyond the limited
Main Methods:
- Conceptual analysis and proposal of a new classification system.
- Comparison of different neurodegenerative diseases and experimental model systems.
Main Results:
- The "prion-like" classification for protein aggregation is insufficient.
- Four key factors are proposed for comparing diseases and models: protein aggregation, seeding potential, role of host factors (e.g., aging, inflammation), and disease-specific mechanisms.
- Different diseases and models are characterized by varying dominance of these factors.
Conclusions:
- A framework considering protein aggregation, host factors, and disease-specific mechanisms offers a clearer understanding of neurodegeneration.
- This approach facilitates the development of targeted therapies by accounting for disease heterogeneity.
- It also improves the translation of findings from model systems to human pathology.
Related Concept Videos
Amyloid Fibrils
11.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.6K
Amyloid Fibrils
6.3K
6.3K
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Subviral Agents
512
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
512
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K

